Ametek (AME) Reports In-Line Q4 EPS; Guides FY16 EPS Above Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
AMETEK Announces Two Acquisitions
February 5, 2016 6:46 AM ESTBERWYN, Pa., Feb. 5, 2016 /PRNewswire/ --Â AMETEK, Inc. (NYSE: AME) today announced that it has completed two acquisitions: Brookfield Engineering Laboratories, the world's leading manufacturer of viscometers and rheometers, and ESP/SurgeX, a leader in energy intelligence and power protection solutions.
"Brookfield Engineering and ESP/SurgeX are excellent acquisitions and strong additions to our Electronic Instruments Group. These businesses will allow us to expand our presence in laboratory instrumentation and power protection, two attractive growth platforms," comments Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.
Brookfield EngineeringBrookfield... More
AMETEK Announces Fourth Quarter 2015 Results
February 5, 2016 6:45 AM ESTBERWYN, Pa., Feb. 5, 2016 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the three month and full year periods ended December 31, 2015.
AMETEK reported fourth quarter 2015 sales of $988.0Â million, down 4% from last year's fourth quarter. Â Excluding realignment costs of $20.7 million, or $0.06 per diluted share, fourth quarter 2015 operating income was down 1% to $229.5Â million, operating margins were up 50 basis points to 23.2%, and diluted earnings per share of $0.63 were unchanged from the fourth quarter 2014 adjusted levels. Â Fourth quarter 2014 adjusted results excluded $5.2Â million, or $0.01 per diluted share, of Zygo integration... More
